Renal Transplantation Dramatically Reduces IgA Anti-beta-2-glycoprotein I Antibodies in Patients with Endstage Renal Disease
Figure 1
(a) Pretransplant levels of IgA aB2GPI in all the patients versus blood donors. (b) Pretransplant levels of IgA aB2GPI in the three subgroups of treatment of renal failure prior to transplantation versus blood donors. BD: blood donors. Pre-Tx: All samples pretransplant. PR: undialyzed patients (predialysis). HD: patients on hemodialysis. PD: patients on peritoneal dialysis. Cut-off is shown with a dotted horizontal line.
